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Q: What Alzheimer’s related studies are you 
involved in currently at the Farber Institute 
for Neurosciences?
Dr. Rovner: We are evaluating three exciting 
new disease-modifying drug treatments that 
may slow down the course of Alzheimer’s 
disease. I am also a Principal Investigator 
of Jefferson’s Center for Excellence in 
Neurodegenerative Diseases funded by
 the Pennsylvania 
Department of Health 
Tobacco Settlement 
grant. We are testing 
innovative screening 
methods to identify 
dementia in 
community-based 
agencies serving older 
adults, as well as 
testing in-home skills training services to 
delay nursing home placement and reduce 
stress for a racially diverse group of family 
caregivers. This latter study is being
conducted at the Center for Applied 
Research on Aging and Health, by Principal 
Investigator Laura N. Gitlin, PhD.
Q: What do study participants gain 
from being part of these research studies?
Dr. Rovner: We have learned that families 
derive a lot of hope and support from
participating in these trials. In general, 
participating in research allows families to 
have the opportunity to get the best possible 
care for their relatives, including potentially 
beneficial treatments before they are available 
to the general public. Being a participant 
may lead to a decrease in the stress of 
caregiving, as well as provide the chance
to make a contribution to new scientific 
knowledge. It is an opportunity to share 
personal experiences so that others
may benefit. 
Q: Are there any risks of participating in 
drug trials?
Dr. Rovner: With trials of medications, there 
are always some risks of side effects, however 
we closely monitor any possible adverse 
reactions. Drugs being studied have already 
been tested before so that we can assure that 
they are reasonably safe. ■
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home to instruct her on practical methods 
she could use to cope with her mother’s 
progressive illness. She began by assessing 
Margaret’s cognitive level as well as Deb’s 
caregiving goals, understanding of the disease 
and willingness to learn new strategies. She 
found that Margaret had a high cognitive 
level and was receiving unnecessary help 
from her caring daughter. “Out of concern 
and an unclear understanding of her mom’s 
abilities, Deb was actually helping her mother 
too much. Deb needed to learn more 
about the disease and she was open to new 
knowledge and adapting strategies to manage 
better day-to-day,” says Vause-Earland.
Based on the assessments, Ms. Vause-Earland 
designed an “action plan” for Deb to follow. 
The plan included specific behavioral goals, 
a summary of Margaret’s abilities or what 
she could still do, and specific strategies for 
Deb to implement to enhance her mother’s 
participation in daily activities and decrease 
her boredom and anxiety. Since Margaret 
was once a housewife, Ms. Vause-Earland 
suggested activities such as washing dishes
or folding laundry — pain-free activities 
that brought her satisfaction, a sense of 
accomplishment, and reflected her previous 
roles and interests. Ms. Vause-Earland also 
helped to establish a nighttime routine for 
Margaret: no coffee, taking a bath, playing 
soothing music and using a nightlight. The 
nightly routine prepared her for bed in a 
relaxed manner and reduced her erratic 
nighttime behavior. 
Beyond these strategies, Ms. Vause-Earland 
taught Deb how to build her own sense of 
efficacy as a caregiver. Through stress-relieving 
techniques and positive reinforcement, 
Ms. Vause-Earland gave Deb confidence and 
built her self-esteem. “Tracey taught me that 
I didn’t need to do everything for Mom; 
that it was okay to let go. She was the first 
person to tell me that I was doing a good 
job,” says Deb. 
Ms. Vause-Earland saw Deb transform as a 
result of her participation in Project COPE. 
“Deb’s energy and enthusiasm and readiness 
to integrate new strategies into her daily 
caregiving transformed her situation,” 
asserts Vause-Earland. “By the end of her 
participation in the study, she had much 
more confidence in her abilities and a sense 
of mastery. Deb now feels empowered, 
more in control of her situation.”
Today, Deb is successfully coping with her 
mother’s disease and both are much happier 
as a result. “My mother now feels like she’s 
part of the family, rather than looking in 
from the outside. She’s happier now that 
I’m letting her be her. She is what she is 
today. You enjoy it and celebrate it. A 
tremendous burden has been lifted off 
of my shoulders.”
CARAH is still enrolling participants 
for Project COPE. For more information 
or to enroll in the study, please call 
215-503-2897. ■
This article appeared in the July 18-31, 2007 
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Did You Know?
As many as 80 percent of persons 
with dementia are cared for in their 
homes by family members.
“Participating in research allows 
families ...to get potentially 
beneficial treatments for 
their relatives before they are 
available to the general public.”
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